Haseki Training and Research Hospital
Istanbul, Sultangazi, 34265, Turkey (Türkiye)
Location contact
Hilal Caglar, M.D
CONTACT
Onur Coban, M.D
CONTACT
NCT Number: NCT07258901
This prospective observational study aims to evaluate the effectiveness and safety of different postoperative analgesia methods used in patients undergoing percutaneous nephrolithotomy (PCNL). Analgesia techniques are determined independently by the responsible anesthesiologist as part of routine clinical practice, and the study team does not intervene in treatment decisions.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Observational
Istanbul, Sultangazi, 34265, Turkey (Türkiye)
Hilal Caglar, M.D
CONTACT
Onur Coban, M.D
CONTACT
This is a prospective observational clinical study designed to examine the impact of various postoperative analgesia strategies on pain outcomes in patients undergoing percutaneous nephrolithotomy (PCNL). In routine practice at the participating center, regional block techniques and intravenous analgesia protocols are commonly used, and different anesthesiologists may choose different postoperative analgesia approaches.
All patients will undergo standard general anesthesia according to institutional protocols. Intraoperative monitoring will include heart rate, mean arterial pressure, oxygen saturation, duration of surgery, opioid consumption, and intraoperative complications. Postoperative follow-up will include assessment of pain scores (NRS) at 0, 2, 6, 12, and 24 hours, cumulative opioid consumption, need for rescue analgesics, time to first analgesic request, incidence of postoperative nausea and vomiting (PONV), antiemetic use, patient satisfaction, and any analgesia-related adverse events.
Demographic characteristics (age, sex, BMI, ASA status), stone features (location, side, volume), and intraoperative variables will be recorded. Data will be collected prospectively and stored securely.
The primary goal is to compare the effect of different postoperative analgesia methods on cumulative opioid use in the first 24 hours. Secondary aims include evaluating pain scores, rescue analgesic need, intraoperative opioid use, time to first analgesic request, PONV incidence, patient satisfaction, and adverse effects.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Coagulopathy or contraindication to regional anesthesia
BMI > 35 kg/m²
Cognitive or communication impairment affecting pain evaluation
Neurological or psychiatric disorders
Musculoskeletal abnormalities
Chronic opioid use, alcohol or substance abuse history
Previous PCNL or open renal surgery on the same side
Refusal to participate
Time frame: 24 hours
Cumulative opioid consumption in the first 24 hours
Time frame: 0, 2, 6, 12, and 24 hours postoperatively
Pain intensity measured using the Numeric Rating Scale (NRS), a validated 11-point pain scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores represent worse pain
Time frame: Postoperative 24 hours
Time to first analgesic request
Time frame: 24 hours
Need for rescue analgesics
Time frame: During surgery
Intraoperative opioid consumption
Time frame: 24 hours
Antiemetic medication use
Time frame: 24 hours postoperatively
Patient satisfaction regarding postoperative analgesia, assessed using a Numeric Rating Scale (NRS) ranging from 0 to 10, where 0 represents no satisfaction and 10 represents the highest possible satisfaction. Higher scores indicate better satisfaction.
Istinye University
Other
Optimizing Postoperative Pain Management After Percutaneous Nephrolithotomy: A Comparative Clinical Assessment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06826833
Agnosia, Analgesia
Tekirdağ, Turkey (Türkiye)
View Trial DetailsNCT05845281
Agnosia, Analgesia
Van, Turkey (Türkiye)
View Trial DetailsNCT04998435
Agnosia, Analgesia
Cairo, Egypt
View Trial DetailsNCT07718802
Calculi, Female Urogenital Diseases
Philadelphia, Pennsylvania, United States
View Trial Details